Trial intelligence / Profile preview

PFK Sedation vs General Anesthesia in Minor Urological Procedures

NCT04285528Completed

Sponsor
University of Jordan
Start
Apr 2019
Primary completion
Dec 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of ketamine in urologic disease (2 arms), sponsored by University of Jordan. Primary endpoint: Blood pressure stability at 45 minutes. Started Apr 2019; status: completed.

02

Drugs

ketamine
03

Conditions

urologic disease

Beyond the preview

Go deeper on NCT04285528.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04285528.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call